Menarini-Silicon Biosystems unveiled the DEPArray NxT digital cell-sorting system at the annual meeting of the American Association for Cancer Research.
The DEPArray NxT automated cell-sorting system separates pure single cells or group of cells from heterogeneous samples for clinical oncology research applications. The genetic analysis of isolated cells provides insights into tumors and allows for the identification of possible molecular targets for therapy and the monitoring of disease progression.
The new system is scheduled to be available in this fall, according to the company. — Joya Patel